AAD’s work with CDC on mpox guidance demonstrates dermatology’s expertise

When the mpox emergency began, we quickly formed a task force to address it and provide members and the public with guidance on the condition and how to identify and treat it. You should expect nothing less!

You may not have expected that we were also asked by the Centers for Disease Control and Prevention to create guidance for clinicians on managing scarring in mpox patients as well as guidance on managing severe mpox lesions. This content is being shared by the CDC on its website, dramatically extending the reach of our work and demonstrating the value of dermatologic knowledge and expertise. You can view the information at www.aad.org/mpox.

We also expanded our COVID-19 registry to encompass mpox and reactions to mpox vaccinations. Dr. Esther Freeman, who led our registry work for both conditions, also participated in World Health Organization efforts to respond to the mpox emergency, developing an atlas of mpox images and guidance for treatment.

The AAD will always offer members and the public the best, most thoroughly vetted guidance it can regarding dermatologic diseases and treatments. We’re proud that our work is being noticed and even requested by organizations like the CDC, allowing us to share dermatology’s unique expertise with the world.